Sirona Biochem
950-789 West Pender Street
Vancouver
British Columbia
V6C 1H2
Canada
Tel: 604-641-4466
Fax: 604-608-5471
Website: http://www.sironabiochem.com/
Email: info@sironabiochem.com
103 articles about Sirona Biochem
-
Sirona Biochem Announces Research Collaboration With Aegilops Applications
10/20/2014
-
Sirona Biochem: Obagi Medical Products, Inc. Begins Manufacturing Scale-Up of Skin Lightening Agent
10/7/2014
-
Sirona Biochem Launches Anti-aging Preclinical Studies
9/23/2014
-
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes
9/4/2014
-
Sirona Biochem Launches Global Awareness Campaign With Cousteau Ambassadors' Video
8/21/2014
-
Sirona Biochem Announces Successful Synthesis Of Anti-Inflammatory Compound For Bloom Burton & Co. Joint Venture
7/31/2014
-
Sirona Biochem Announces Successful Completion of Two First Line Studies By Wanbang Biopharmaceuticals
7/23/2014
-
Sirona Biochem Announces Shares For Services Agreement
7/23/2014
-
Sirona Biochem - CEO Letter To Shareholders
7/21/2014
-
Sirona Biochem Announces Wanbang Biopharmaceuticals's Launch Of Pre-Clinical Validation
6/3/2014
-
Sirona Biochem Expands Exclusive Skin Lightening License With Valeant Pharmaceuticals International To Include AMBI And Kinerase
5/29/2014
-
Sirona Biochem's Science Boosts Anti-Aging Technology
5/27/2014
-
Sirona Biochem Announces Open Webinar For Q&A
4/3/2014
-
Sirona Biochem Welcomes Claude Nivet, New Laboratory Operations Manager At TFChem
3/24/2014
-
Sirona Biochem Arranges $1.2M Private Placement
2/26/2014
-
Sirona Biochem Arranges $1.2 Million Private Placement
2/26/2014
-
Sirona Biochem Featured In National Post
2/7/2014
-
Wanbang Biopharmaceuticals In-licenses Diabetes Drug Rights From Sirona Biochem Of Canada
1/27/2014
-
Sirona Biochem Announces License Agreement With Cincinnati Children's Hospital Medical Center
1/15/2014
-
Fosun Pharma Subsidiary to In-License Diabetes Drug From Canadian Pharma
8/20/2013